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Background: Controversy still exists about the breast carcinogenic properties in humans of
environmental xenoestrogens (organochlorines), justifying new investigations.
Aims: To compare the blood levels of total dichlorodiphenyltrichloroethane (DDT) and hexachloroben-
zene (HCB) in samples collected at the time of breast cancer discovery, in order to avoid the potential
consequences of body weight change (after chemotherapy or radiotherapy) on the pesticide residue
levels.
Methods: Blood levels of HCB and total DDT (we calculated total DDT concentrations by adding all
DDT and DDE isomers) were compared in 159 women with breast cancer and 250 presumably healthy
controls. Risk of breast cancer associated with organochlorine concentration was evaluated.
Results:Mean levels of total DDT and HCB were significantly higher for breast cancer patients than for
controls. No differences in serum levels of total DDT or HCB were found between oestrogen receptor
positive and oestrogen receptor negative patients with breast cancer.
Conclusions: These results add to the growing evidence that certain persistent pollutants may occur in
higher concentrations in blood samples from breast cancer patients than controls.
Breast cancer is the most common cancer in women,affecting one out of every 10 women in Europe and theUSA. If some of the newly detected breast cancers can be
explained by improved detection, it is also true that the
incidence of the disease cannot completely be elucidated in
such a way.
Over the past decade, there has been increasing interest in
the so called environmental endocrine disrupters, in particular
when such compounds are acting as oestrogens or
antiandrogens.1 Current knowledge provides limited evidence
for linking human exposure to endocrine disrupters and risk
of cancer development.1 Little is known about the human
consequences of long term exposure to mixtures of multiple
chemicals, even in small amounts. Important questions
concern the lifetime period of exposure (in utero, neonatal
period, infancy, and adulthood), the long latency between
exposure and the potential event, and the cumulative risk of
exposure to multiple products during different time periods.
On the other hand, a marked increase in the incidence of can-
cer has been observed during the past decades, especially for
breast, prostate, and testis cancer. It is well known that the
aetiology of breast cancer has a strong hormonal component.
The relation between exposure to oestrogenic compounds and
risk of breast cancer was highlighted by the evidence of devel-
opment of carcinoma of the vagina and cervix in daughters of
women treated with pharmacological doses of diethylstil-
boestrol (DES) during pregnancy.2 The mothers themselves
developed 35% more breast cancers.
Some pesticides, especially organochlorines, are known to
induce biological responses comparable to those of endog-
enous oestrogens, such as increased uterine weight and vagi-
nal epithelial cornification.3 Several experimental studies have
shown the promoting activity of organochlorine compounds
in the development of oestrogen related tumours in
animals.4 5 Studies of human organochlorine exposure have
been mostly conducted among populations with known or
suspected occupational or accidental exposure.3 6 However,
almost every single individual is daily exposed to much lower
concentrations of environmental compounds through dietary
habits, water source, and the food chain.
Several epidemiological studies have been published on the
risk of breast cancer in association with blood or fat
concentrations of organochlorines, especially p,p′-DDE (1,1-
dichloro-2,2-bis (4-chlorophenyl) ethylene) the main metabo-
lite of the 1,1,1-trichloro-2,2-bis (4-chlorophenyl) ethane
(DDT) insecticide, whose use is prohibited today in the USA,
Canada, and Europe, but which was largely employed in the
past and is still used extensively for mosquito control in
developing countries. In a study published by Wolff et al in
1993,7 breast cancer was strongly associated with the concen-
tration of DDE in serum. The author reported a fourfold
increase in the relative risk of developing breast cancer when
serum DDE concentrations rose from 2.0 ppb to 19.1 ppb. In
1994, another study8 suggested that women with oestrogen
receptor positive breast tumours had a higher body burden of
DDE than women with benign breast diseases or oestrogen
receptor negative breast tumours. In the case-control study of
Krieger and colleagues,9 no difference was found between the
average DDE serum concentrations of cases and controls, thus
rejecting the hypothesis of a link between exposure to DDT
and risk of breast cancer. Interestingly, when restricting the
material of Krieger et al to blacks and whites separately, the
results were positive (tendency towards significance) for
white women. Conversely, Hunter and colleagues10 did not
observe any evidence of an increased risk of breast cancer
among women with relatively high concentrations of plasma
DDE.
Based on combined analysis of the studies which report
DDE concentrations in breast cancer and control patients,
Safe11 concluded that the hypothesised linkage between envi-
ronmental oestrogens and the increased incidence of breast
cancer is unproven. Although many agree with this,12–14 others
estimate that there is a pattern of epidemiological data15–18 that
offers a possible resolution to several anomalies in breast can-
cer research. Consequently, reductions in exposure will
provide an opportunity for primary prevention of this disease.
Clearly, it appears that more investigations are required to
evaluate the interactions between environmental exposure
and established risk factors.
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In the present study, blood samples were collected from two
groups of women. The first group (cases) consisted of patients
with confirmed breast cancer, and the second group (controls)
included presumably healthy women. We focused on two pes-
ticides with oestrogenic activity: total DDT (calculated by add-
ing all DDT isomers: op′-DDT, pp′-DDT, op′-DDE, and
pp′-DDE) and HCB (hexachlorobenzene) were quantified
simultaneously using a gas chromatographic analyser coupled
to an ion trap mass spectrometer detector. Serum concentra-




The present retrospective study involved 600 women who
underwent a medical examination between September 1999
and February 2000 in the Department of Gynaecology or
Department of Endocrine Surgery. These women were
referred to hospital after a doubtful mammographic preven-
tive screening. Women who had a palpable breast mass or
mammographic abnormality underwent a biopsy, and from
this initial group, 159 women (54.21 (12.12) years of age) suf-
fering from breast cancer and hospitalised for a mastectomy or
tumourectomywere considered as cases. Control subjects were
selected at random in a population of women free of any
known cancer consulting for routine vaginal cytological
examinations at Sart Tilman University Hospital. For each
case patient,wematched at least one control subject according
to the year of birth, menopausal status, reproductive history
(no child or at least one child), and date of blood sampling. All
patients gave their informed consent for participating in the
study. For controls (250 women, 53.29 (12.35) years of age),
blood specimens were taken at the time of the examination,
whereas for women with breast cancer, samples were collected
prior to surgical intervention. Blood samples were immedi-
ately centrifuged and serum specimens kept frozen at −18°C
until assay (within one week).
For each subject, information regarding age, smoking hab-
its, living environment (urban or rural), pregnancy, breast
feeding, and menopausal status was recorded from a
questionnaire. For women with breast cancer, tumour size and
oestrogen receptor status were determined from laboratory
and medical examinations. Other data, such as specific dietary
histories, were unavailable.
Methods
Total DDT and HCB in serum were identified and quantified
using a gas chromatographic analyser coupled to an ion trap
mass spectrometer detector (Saturn 2000, Varian). The
analytical method is described elsewhere.19 Briefly, sample
preparation included a liquid-liquid extraction (petroleum
ether:diethylether, 98:2) followed by a solid phase extraction
(Bond Elut Certify, Varian). The eluate was evaporated to dry-
ness, reconstituted, and then injected into the gas chromato-
graph (Saturn 2000, Varian). All solvents were pesticide grade
quality. Reference standards of all pesticides were obtained
from Cambridge Isotope Laboratories (Andover, MA, USA).
The calibration curve was constructed from 0 to 40 ppb and
linearity applied for this concentration range. Endosulfan-d4
(0.5 ppb) was used as internal standard. Limits of quantifica-
tion were defined as 10 times the standard deviation (SD) of
the results from the lowest quality control serum pool over the
course of the analyses (n = 15). These limits were approxi-
mately 0.5 ppb for all organochlorines (with coefficients of
variation from 4.6% to 7.8%). Samples were analysed in dupli-
cate in batches that included breast cancer and control
samples, together with pooled serum quality control samples.
Analytical personnel were blind to the nature of the samples.
Two positive samples from the first batch (one from the cancer
group and one from the control group) were quantified with
every batch of new samples; the corresponding coefficients of
variation were respectively 6.3% and 4.1%. Expression of the
results on a lipid basis (total serum lipid content calculated
from measurements of cholesterol and triglycerides at the
time of analysis) was compared with non-adjusted results; as
no difference could be found (all subjects were fasting
individuals), only crude results are presented here.
Statistical analysis
Results were expressed as mean (SD). When the quantifica-
tion of organochlorines gave results lower than our quantifi-
cation limit, we recorded a “0” value in our data table and
these results were included in all statistical analyses. Concen-
trations of total DDT and HCB between matched cases and
controls were compared using the Mann-Whitney U test. The
χ2 test was used to compare the proportion of smokers and
non-smokers, of breast feeding history, and of rural and urban
women in the two groups. Spearman’s correlation coefficient
was completed to assess the relation between pesticide serum
concentration and age, or, for women with breast cancer,
tumour size and oestrogen receptor status. Odds ratios (ORs)
were calculated for total DDT and HCB positive cases in order
to test the association between organochlorine residues and
breast cancer. Adjusted ORs were calculated using conditional
logistic regressionmodels in order to evaluate the influence on
crude results of the simultaneous presence of DDT congeners
and HCB, and also of breast feeding (either yes or no, duration
of lactation not available). All results were considered to be
significant at the 5% critical level.
RESULTS
The two groups of women were similar with respect to smok-
ing habits (50% v 44% smokers, p = 0.53), living environment
(56% v 52% urban, p = 0.66), and breast feeding report (48.1%
v 49.4%).
The most frequently observed organochlorine was p,p′-DDE
(83.54%). HCB was detected in 18.35% of samples. In the con-
trol group, 60 women (24.0%) were without any detectable
pesticide residue, while there were only four (2.5%) in the
breast cancer group. A DDT congener together with HCB was
found simultaneously in two samples from the control group
(0.8%) and in four samples from the cases (2.5%).
Figure 1 shows total DDT and HCB distributions in cases
and controls. The mean concentration of total DDT was
Figure 1 Total DDT and HCB distribution in controls (n = 250) and
cases (n = 159).
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significantly higher in women with breast cancer than in con-
trol subjects (3.94 (3.88) v 1.83 (1.98) ppb, p < 0.0001). The
same conclusion applied for HCB (0.79 (1.65) ppb for cases
and 0.09 (0.41) for controls, p = 0.0005).
We determined the ORs and confidence intervals for total
DDT and HCB at the limit of quantification threshold concen-
tration in order to measure the association between the pres-
ence of detectable concentrations of DDT congeners or HCB
and breast cancer (see table 1). Results were not affected if a
DDT congener and HCB were present simultaneously. After
adjustment was made for breast feeding, crude results were
not dramatically affected (see table 1).
Levels of total DDT were related to age (r = 0.20, p = 0.02),
but HCB concentrations were not (r = −0.04, p = 0.62). The
serum total DDT or HCB concentrations were independent
from smoking habits (respectively, p = 0.54 and p = 0.81) or
living environment (respectively, p = 0.58 and p = 0.27). In
the breast cancer group, oestrogen receptor status was
available for 102 women but was not correlated with the total
DDT concentration (r = 0.02, p = 0.88) or the HCB concentra-
tion (r = 0.09, p = 0.49). Tumour size was recorded in 90
cases. No correlation was found between this parameter and
serum total DDT concentrations (r = 0.15, p = 0.20) or serum
HCB concentrations (r = 0.05, p = 0.65).
DISCUSSION
Endogenous hormones have been linked to the development
of a wide variety of animal and human cancers. This is
particularly true for breast cancer, where risk is increased by a
prolonged reproductive life,20 whereas a premature meno-
pause is protective.21 The association of DDT, an organochlo-
rine insecticide, with egg fragility and reduced eggshell
calcium in several types of birds, suggested that endocrine
reproductive mechanisms in animals might be altered by
ingested pesticides.22 Widespread use of DDT began in the
United States in 1946 and increased until 1959. It then
declined steadily until it was effectively stopped in 1972.23 DDT
accumulates in the body, mainly in adipose tissue, and has a
half life of 10–50 years.1 DDT and its major metabolite, DDE,
have been shown to have oestrogenic properties in vitro and
also in vivo.5 22 24 The potential link between an increased inci-
dence of breast cancer and a synchronous period of
widespread pesticide use requires clarification. Previous stud-
ies have investigated the possible association between the
blood or fat concentrations of organochlorines and breast
cancer, but controversy remains because of the conflicting
results, especially because all the epidemiological studies dif-
fer by the detected compounds, the selected population, the
time of blood sampling, and also the analytical methods
used.7–18 25–28
In our study, samples were analysed at a maximum of one
week following collection and results were not affected by
conservation. As in the study of Krieger and colleagues,9 our
results were not affected by differences in serum lipids related
to dietary intake immediately prior to sampling, since case
patients and controls had undergone overnight fasting prior to
venepuncture. A limitation of our study is that serum
specimens were collected retrospective to the diagnosis of
breast cancer. Cancer is known to induce changes in metabo-
lism and body weight, and these are not accounted for in the
present study, so that a misclassification of exposure cannot be
excluded. However, breast cancer was always the primary
tumour and the sampling occurred before surgery and
treatments such as chemotherapy or radiotherapy, so that
misclassification of exposure owing to treatment does not
seem to occur.
The p,p′-DDE concentrations were similar to those observed
by Wolff and colleagues,7 even if the highest value obtained in
our study was slightly lower (20 ppb) than that obtained in
the study of Wolff et al (44.3 ppb). Serum concentrations were
much higher in the study of Krieger and colleagues9 for blood
samples collected between 1964 and 1971. This probably
reflects the progressive decline in DDE concentrations, as
illustrated by many studies related to human milk.29–31 This
trend should accompany reduced risk of any disease
associated with DDT exposure.
Our results show a significant difference of organochlorines
concentrations between cases and controls. These observa-
tions are in agreement with the first results published byWolff
and colleagues7 and Dewailly and colleagues,8 but fail to
establish a positive correlation between DDT concentrations
and the oestrogen receptor status in the breast cancer group.
In the study of Krieger and colleagues,9 the authors concluded
that, overall, there was no evidence of increased breast cancer
risk for the higher DDE concentrations, while for the white
subpopulation, a positive association was found. Since our
study population comprised only white women, our finding of
increased risk of breast cancer after DDT exposure is in agree-
ment with results of Krieger et al, and strongly suggests that
the interethnic variation showed by Krieger et al was not the
result of chance. A potential explanation of the Krieger et al
results could be the balance between breast cancer risk factors
and antioestrogenic compounds (phytoestrogens, for exam-
ple) in the Asian cohort. Identification and quantification of
such protective compounds may have a pronostic significance.
An interesting result of the present study is the association
between HCB and breast cancer. HCB has been shown to be
present at higher concentrations in breast adipose tissue of
women suffering from breast cancer than control tissues.32 33
Although these data are also not proven,34 a tumour promoting
activity of HCB on human breast epithelial cells has been
reported,35 which is consistent with the present findings. No
correlation between HCB concentration and oestrogen recep-
tor status was shown.
These data warrant further analysis, and consideration of
possible exposure routes or dietary intake. Carcinogenesis is a
multifactorial event, and it is important to try to clarify the
role of chemicals in cancer development.
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Table 1 Breast cancer risk as estimated by crude and adjusted ORs for total DDT and HCB at 0.5 ppb threshold level
(LOQ)
Above LOQ (0.5 ppb) Cases (%) Controls (%) OR (95% CI) Adjusted OR (95% CI) Adjusted OR‡ (95% CI)
Total DDT 95.57 72.30 5.36 (1.89 to 15.19) 5.66* (1.83 to 17.51) 5.64 (1.81 to 17.65)
HCB 31.65 4.00 8.68 (2.83 to 26.62) 9.06† (2.81 to 29.21) 9.14 (2.84 to 29.41)
OR, odds ratio; CI, confidence interval; LOQ, limit of quantification.
*Adjusted OR for total DDT when taking HCB presence into account; †adjusted OR for HCB when taking total DDT presence into account.
‡OR adjusted for breast feeding history.
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